$23.54
+14%Oscar Health, Inc. provides health insurance products and services in the United States. The company offers Individual & Family, Small Group, and Medicare Advantage plans, as well as +Oscar, a technology driven platform designed to help providers and payor clients to engage with members and patients. It also provides reinsurance products. The company was formerly known as Mulberry Health Inc. and changed its name to Oscar Health, Inc. in January 2021. Oscar Health, Inc. was incorporated in 2012 and is headquartered in New York, New York.
Chief Accounting Officer
Chief Executive Officer & Director
Compensation
$915,000
Chief Financial Officer
Compensation
$1,446,900
Chief People Officer
Co-Founder & Vice Chairman
Co-Founder, Chief Technology Officer & Director
Compensation
$1,656,000
EVice President & Chief Legal Officer
Executive Vice President of Public Affairs
Compensation
$921,900
President of Oscar Medical Group
Senior Advisor
Compensation
$575,000
Vice President of Treasury & Investor Relations
During the last 12 months, insiders have purchased $11.92M and sold $26.01M worth of OSCR shares, resulting in $14.09M of net selling activity.
1.0M
11.92M
201.3K
4.86M
+7.1M
+$7.06M
0
0.00
448.1K
6.88M
-6.9M
-$6.88M
0
0.00
848.9K
14.27M
-14.3M
-$14.27M
0
0.00
0
0.00
+0
+$0
Bertolini Mark T
Director, Officer: Chief Executive Officer
$11.92M
Schlosser Mario
Director, Officer: President Of Technology & Cto
$19.84M
Blackley Richard Scott
Officer: Chief Financial Officer
$5.54M
Mcananey Adam
Officer: Chief Legal Officer
$281K
Liang Janet
Officer: President, Oscar Insurance
$222K
Baltrus Victoria
Officer: Chief Accounting Officer
$131K
Negative insider sentiment with $14.09M net selling. Selling notably exceeds buying, warranting closer scrutiny of company fundamentals.
Weak buy/sell ratio. Selling significantly exceeds buying—monitor for potential fundamental concerns.
Very strong recent buying momentum. Recent insider purchases significantly outpace sales, suggesting near-term optimism.
5 insider sellers vs. 1 buyers. Widespread selling across multiple insiders may signal concerns.
OSCR - Filing history and reports
| Filing Type | Filing Date | Period Ending | Fiscal Year | Actions |
|---|---|---|---|---|
DEF 14A DEF 14A 2026 N/A | April 22, 2026 | June 04, 2026 | 2026 | |
DEF 14A DEF 14A 2025 N/A | April 25, 2025 | June 04, 2025 | 2025 | |
DEF 14A DEF 14A 2024 N/A | April 25, 2024 | June 06, 2024 | 2024 | |
DEF 14A DEF 14A N/A | April 27, 2023 | April 27, 2023 | ||
DEF 14A DEF 14A 2022 N/A | April 26, 2022 | June 09, 2022 | 2022 |
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.